Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Vertex/Kissei select development candidate from p38 MAP kinase inhibitor program

July 8, 1998

Long-term safety and efficacy data presented for Enbrel

July 8, 1998

Series of MMP and TACE inhibitors patented by American Cyanamid

July 7, 1998

Boston Life Sciences submits further data supporting Therafectin NDA

July 3, 1998

Additional phase III results reported for Cypress Bioscience's Prosorba Column

July 1, 1998

Celltech scientists discover potent and selective inhibitors of protein kinases

June 26, 1998

HMR discloses preparation and use of series with MMP-inhibitory activity

June 26, 1998

Enbrel BLA accepted for review and assigned priority review status

June 25, 1998

Idun discloses new inhibitors of ICE and related proteases

June 24, 1998

Collgard Biopharmaceuticals establishes U.S. subsidiary

June 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...